Time-restricted Eating and Interval Training With Digital Follow-up
TREHIIT-DFU
Effects of Time-restricted Eating and Interval Training With Digital Follow-up: A Randomized Controlled Trial
1 other identifier
interventional
52
1 country
1
Brief Summary
This study will investigate the effects of seven weeks of time-restricted eating combined with high-intensity interval training compared with a control group on body composition in adults with overweight/obesity. Participants in the intervention group will complete the intervention remotely and will receive weekly follow-up through online platforms (telephone, video call). Before and after the intervention, the investigators will measure the participants' body composition, physical fitness, fasting blood glucose and insulin, blood lipids, and blood pressure. Physical activity, diet, sleep quality, appetite, and adherence to the intervention will also be measured. Secondary sub-analyses of sex differences in the responses to the intervention will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2022
CompletedFirst Posted
Study publicly available on registry
August 17, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 13, 2024
CompletedJune 21, 2024
June 1, 2024
1.7 years
August 16, 2022
June 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total fat mass
Change in total fat mass measured with bioelectrical impedance analysis
From baseline to after 7 weeks of intervention
Secondary Outcomes (21)
Blood glucose
From baseline to after 7 weeks of intervention
Insulin
From baseline to after 7 weeks of intervention
Average glucose levels
From baseline to after 7 weeks of intervention
Blood Cholesterol
From baseline to after 7 weeks of intervention
HDL-cholesterol in blood
From baseline to after 7 weeks of intervention
- +16 more secondary outcomes
Other Outcomes (6)
Adherence to high-intensity interval training
Seven weeks
Compliance to high-intensity interval training
Seven weeks
Adherence to time-restricted eating
Seven weeks
- +3 more other outcomes
Study Arms (2)
Time-restricted eating and high-intensity interval training
EXPERIMENTALSeven weeks of time-restricted eating and high-intensity interval training with digital follow-up.
Control
NO INTERVENTIONNo intervention nor digital follow-up for seven weeks.
Interventions
Maximal daily eating window of 10 hours and high-intensity interval training (three weekly, unsupervised, aerobic exercise sessions performed at \> 90 % heart rate maximum). Each exercise session will last for 33-38 minutes. Participants will receive digital follow-up once weekly. The intervention period will be seven weeks,
Eligibility Criteria
You may qualify if:
- Body mass index ≥ 27 kg/m²
- Able to walk or ride a bike \> 60 min
You may not qualify if:
- On-going pregnancy
- Lactation within 24 weeks of study commencement
- High-intensity exercise ≥ 1/week
- Habitual eating window ≤12 hours/day
- Taking hypertension, glucose-, or lipid-lowering drugs
- Body mass variation ≥ 4 kg three months prior to study commencement
- Known diabetes mellitus (type 1 or 2) or cardiovascular disease
- Working night shifts
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of circulation and medical imaging, NTNU
Trondheim, 7491, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Øivind Rognmo, PhD
Norwegian University of Science and Technology, Trondheim, Norway
- PRINCIPAL INVESTIGATOR
Trine Moholdt, PhD
Norwegian University of Science and Technology, Trondheim, Norway
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2022
First Posted
August 17, 2022
Study Start
September 1, 2022
Primary Completion
May 13, 2024
Study Completion
May 13, 2024
Last Updated
June 21, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share